MARIOS07/iStock via Getty Images Introduction Intuitive Surgical's (NASDAQ:ISRG) stock has rallied another 17% since my Q1 earnings preview in April. I recommended a "buy," noting the company's dominance in robotic surgery, growth, and impressive financial performance. To no surprise, the company delivered solid Q1 results, posting revenues of $1.89 billion and EPS of $1.51, both beating estimates. The article below looks ahead to Q2 earnings. Intuitive Surgical Eyes Revenue Boost with da Vinci 5 Upgrad ...